Paul Tudor Jones's VIR Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 73,504 shares of Vir Biotechnology, Inc. (VIR) worth $658,596, representing 0.00% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in VIR, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 68,574 shares. Largest reduction occurred in Q2 2025, reducing 68,349 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Vir Biotechnology (VIR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vir Biotechnology (VIR) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +4,930 | Add 7.19% | 73,504 | $8.96 |
| Q4 2025 | +68,574 | New Buy | 68,574 | $6.03 |
| Q2 2025 | -68,349 | Sold Out | 0 | $0.00 |
| Q1 2025 | +68,349 | New Buy | 68,349 | $6.48 |
| Q4 2024 | -68,113 | Sold Out | 0 | $0.00 |
| Q3 2024 | +209 | Add 0.31% | 68,113 | $7.49 |
| Q2 2024 | +3,089 | Add 4.77% | 67,904 | $8.90 |
| Q1 2024 | +64,815 | New Buy | 64,815 | $10.13 |
| Q4 2023 | -67,202 | Sold Out | 0 | $0.00 |
| Q3 2023 | +67,202 | New Buy | 67,202 | $9.37 |
Paul Tudor Jones's Vir Biotechnology Investment FAQs
Paul Tudor Jones first purchased Vir Biotechnology, Inc. (VIR) in Q3 2023, acquiring 67,202 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Vir Biotechnology, Inc. (VIR) for 10 quarters since Q3 2023.
Paul Tudor Jones's largest addition to Vir Biotechnology, Inc. (VIR) was in Q4 2025, adding 68,574 shares worth $413,501.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 73,504 shares of Vir Biotechnology, Inc. (VIR), valued at approximately $658,596.
As of the Q1 2026 filing, Vir Biotechnology, Inc. (VIR) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Vir Biotechnology, Inc. (VIR) was 73,504 shares, as reported at the end of Q1 2026.